Delivery Order SPE2DB20D3101-SPE2DB23FRXL2

Award Date 9/12/23
Potential Completion Date 9/13/23
Potential Value $389
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $455.24 to Amerisourcebergen Drug Corp for the supply of 100 tablets of 2.5 mg methotrexate. The prime contractor, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania by July 27, 2023. The award is issued against an existing DLA contract vehicle to support the agency's medical supply needs. No set-aside designation or subcontractors were...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirteen thousand forty-three dollars and sixty-two cents to Amerisourcebergen Drug Corp for one hundred tablets of two and a half milligram methotrexate. The prime contractor, a division of Amerisourcebergen Corporation, will fulfill the order from its facility in Conshohocken, Pennsylvania by July 24, 2023 under the contract's one-day period of performance. No major subcontractors or set aside designations were...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $199.65 to Amerisourcebergen Drug Corp for the supply of 100 units of 2.5 mg Methotrexate tablets. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility located in Conshohocken, Pennsylvania under a one-day period of performance beginning August 1, 2023. The Defense Logistics Agency routinely utilizes indefinite delivery/indefinite quantity contracts to...
The Defense Logistics Agency awarded a delivery order under an indefinite-delivery/indefinite-quantity contract vehicle to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets at a value of $573.57. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period concluding on July 27, 2023. The firm fixed price contract has no set-aside designation and supports the DLA's medical supply procurement programs. As...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $739 to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 2.5 mg methotrexate. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 21-22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a common drug supports the Agency's mission to provide critical...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $255.24 to Amerisourcebergen Drug Corp for 100 tablets of 2.5 mg methotrexate. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products to its place of performance in Conshohocken, Pennsylvania between August 10-11, 2023. The Defense Logistics Agency routinely procures pharmaceuticals and medical supplies to support Department of Defense operations worldwide. No subcontractors or...
The Defense Logistics Agency awarded a $1,026.06 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 tablets of 2.5 mg methotrexate. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within the period of performance from August 22 to August 23, 2023. The Defense Logistics Agency utilizes contracts such as this to efficiently procure medical supplies in support of the...
The Defense Logistics Agency awarded a $3,441 delivery order to Amerisourcebergen Drug Corp for 100 tablets of 2.5 mg methotrexate. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania under a firm fixed price contract executed from September 26-27, 2023. The parent company, Amerisourcebergen Corporation, will perform through its Corporate Office Division. No subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $4,588 to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. The order was placed under an existing prime vendor contract vehicle to support the Defense Logistics Agency's pharmaceutical procurement programs. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with all supplies to be delivered between September 26-27,...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $9,236 to Amerisourcebergen Drug Corporation for the supply of 100 units of 2.5 mg methotrexate tablets. The order was placed under an existing prime vendor contract vehicle to source pharmaceutical products for various Department of Defense medical treatment facilities. Performance will occur at Amerisourcebergen's distribution center in Conshohocken, Pennsylvania, with delivery required between...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRXL2
    Delivery Order

The Defense Logistics Agency awarded a firm fixed price delivery order valued at $389.48 to Amerisourcebergen Drug Corp for the supply of 100 tablets of 2.5 mg methotrexate. The prime contractor, a division of Amerisourcebergen Corporation, will fulfill the order from its facility located in Conshohocken, Pennsylvania by September 13, 2023. The contract was issued under an existing indefinite-delivery/indefinite-quantity vehicle with the DLA to support its pharmaceutical procurement programs. No subcontractors or set-aside designations were identified in the award information.

Generated 12/20/23, 4:46 AM